Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine
- PMID: 33189715
- DOI: 10.1016/j.pharmthera.2020.107741
Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine
Abstract
Several studies have demonstrated the effectiveness of ketamine in rapidly alleviating depression and suicidal ideation. Intense research efforts have been undertaken to expose the precise mechanism underlying the antidepressant action of ketamine; however, the translation of findings into new clinical treatments has been slow. This translational gap is partially explained by a lack of understanding of the function of time and circadian timing in the complex neurobiology around ketamine. Indeed, the acute pharmacological effects of a single ketamine treatment last for only a few hours, whereas the antidepressant effects peak at around 24 hours and are sustained for the following few days. Numerous studies have investigated the acute and long-lasting neurobiological changes induced by ketamine; however, the most dramatic and fundamental change that the brain undergoes each day is rarely taken into consideration. Here, we explore the link between sleep and circadian regulation and rapid-acting antidepressant effects and summarize how diverse phenomena associated with ketamine's antidepressant actions - such as cortical excitation, synaptogenesis, and involved molecular determinants - are intimately connected with the neurobiology of wake, sleep, and circadian rhythms. We review several recently proposed hypotheses about rapid antidepressant actions, which focus on sleep or circadian regulation, and discuss their implications for ongoing research. Considering these aspects may be the last piece of the puzzle necessary to gain a more comprehensive understanding of the effects of rapid-acting antidepressants on the brain.
Keywords: Circadian; Depression; Plasticity; Rapid-acting antidepressant; Sleep; Slow-wave sleep.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest T.R. and S.K. are listed as co-inventors on a patent application wherein in new tools enabling the development of rapid-acting antidepressants and the efficacy monitors thereof are disclosed based on the basic principles of ENCORE-D. T.R. and S.K. have assigned their patent rights to the University of Helsinki but will share a percentage of any royalties that may be received by the University of Helsinki. All other authors declare that there are no conflicts of interest.
Similar articles
-
A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants.Prog Neurobiol. 2021 Nov;206:102140. doi: 10.1016/j.pneurobio.2021.102140. Epub 2021 Aug 14. Prog Neurobiol. 2021. PMID: 34403718 Free PMC article.
-
Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.Pharmacol Rep. 2021 Apr;73(2):323-345. doi: 10.1007/s43440-021-00232-4. Epub 2021 Feb 20. Pharmacol Rep. 2021. PMID: 33609274 Free PMC article. Review.
-
Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties.Biol Psychiatry. 2017 Sep 1;82(5):361-369. doi: 10.1016/j.biopsych.2017.03.011. Epub 2017 Mar 28. Biol Psychiatry. 2017. PMID: 28457485 Free PMC article.
-
Mechanisms of ketamine action as an antidepressant.Mol Psychiatry. 2018 Apr;23(4):801-811. doi: 10.1038/mp.2017.255. Epub 2018 Mar 13. Mol Psychiatry. 2018. PMID: 29532791 Free PMC article. Review.
-
Encoding, Consolidation, and Renormalization in Depression: Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects.Pharmacol Rev. 2020 Apr;72(2):439-465. doi: 10.1124/pr.119.018697. Pharmacol Rev. 2020. PMID: 32139613 Review.
Cited by
-
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities.CNS Neurol Disord Drug Targets. 2024;23(9):1085-1100. doi: 10.2174/0118715273254093231020052002. CNS Neurol Disord Drug Targets. 2024. PMID: 37885113 Review.
-
(S)-Ketamine but Not (R)-Ketamine Shows Acute Effects on Depression-Like Behavior and Sleep-Wake Architecture in Rats.Int J Neuropsychopharmacol. 2023 Sep 25;26(9):618-626. doi: 10.1093/ijnp/pyad050. Int J Neuropsychopharmacol. 2023. PMID: 37578355 Free PMC article.
-
A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants.Prog Neurobiol. 2021 Nov;206:102140. doi: 10.1016/j.pneurobio.2021.102140. Epub 2021 Aug 14. Prog Neurobiol. 2021. PMID: 34403718 Free PMC article.
-
Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.Pharmacol Rep. 2021 Apr;73(2):323-345. doi: 10.1007/s43440-021-00232-4. Epub 2021 Feb 20. Pharmacol Rep. 2021. PMID: 33609274 Free PMC article. Review.
-
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression.Ther Adv Psychopharmacol. 2024 Mar 4;14:20451253241231264. doi: 10.1177/20451253241231264. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 38440104 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous